Prostate Cancer Patients Treated by Radiotherapy Clinical Trials

8 recruiting

Prostate Cancer Patients Treated by Radiotherapy Trials at a Glance

8 actively recruiting trials for prostate cancer patients treated by radiotherapy are listed on ClinicalTrialsFinder across 6 cities in 7 countries. The largest study group is Not Applicable with 2 trials, with the heaviest enrollment activity in Myrtle Beach, Munich, and Albuquerque. Lead sponsors running prostate cancer patients treated by radiotherapy studies include Clarity Pharmaceuticals Ltd, Hong Kong Sanatorium & Hospital, and Candel Therapeutics, Inc..

Browse prostate cancer patients treated by radiotherapy trials by phase

Treatments under study

About Prostate Cancer Patients Treated by Radiotherapy Clinical Trials

Looking for clinical trials for Prostate Cancer Patients Treated by Radiotherapy? There are currently 8 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Prostate Cancer Patients Treated by Radiotherapy trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Prostate Cancer Patients Treated by Radiotherapy clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 18 of 8 trials

Recruiting

Study of the Epidemiological, Clinical, Diagnostic, and Therapeutic Characteristics of Prostate Cancers in Algeria

Prostate CancerProstate Cancer MetastaticProstate Cancer (Adenocarcinoma)+3 more
Société Algérienne de Formation et Recherche en Oncologie2,000 enrolled24 locationsNCT07484971
Recruiting
Phase 3

64Cu-SAR-bisPSMA Positron Emission Tomography: A Phase 3 Study of Participants With Biochemical Recurrence of Prostate Cancer

Prostate CancerCryotherapyProstate Cancer Recurrent+3 more
Clarity Pharmaceuticals Ltd220 enrolled28 locationsNCT06970847
Recruiting
Phase 2

A Biomarker Study in Men With Localized Prostate Cancer Treated With Aglatimagene Besadenovec

Prostate Cancer (Adenocarcinoma)Prostate Cancer Patients Treated by Radiotherapy
Candel Therapeutics, Inc.45 enrolled7 locationsNCT07332000
Recruiting

SpaceOAR Post-Market Registry Study

Prostate Cancer Patients Treated by Radiotherapy
Sheffield Teaching Hospitals NHS Foundation Trust320 enrolled8 locationsNCT07300631
Recruiting
Not Applicable

Two-fraction Proton Therapy With MRI Guidance for Prostate Cancer: A Phase II Trial

Prostate Cancer Patients Treated by Radiotherapy
Hong Kong Sanatorium & Hospital35 enrolled1 locationNCT07130682
Recruiting
Phase 2

Hypofractionated Radiotherapy With a Focal Microboost for High-Risk and Locally Advanced Prostate Cancer

Prostate CancerProstate Cancer Patients Treated by Radiotherapy
Medical University of South Carolina46 enrolled1 locationNCT07325721
Recruiting

Immune Biomarkers in Prostate Cancer Patients Treated With Brachytherapy

Prostate Cancer RecurrentProstate Cancer (Diagnosis)Prostate Cancer Patients Treated by Radiotherapy+1 more
University of Erlangen-Nürnberg Medical School200 enrolled3 locationsNCT07131956
Recruiting
Not Applicable

The Effect of a Structured Strength and Endurance Training Program on Quality of Life, Fitness, Blood Parameters and Survival in Prostate Cancer Patients

Prostate CancerMetastatic Prostate CancerProstate Cancer (Post Prostatectomy)+2 more
Ludwig-Maximilians - University of Munich150 enrolled1 locationNCT07126860